Chromicent

We are pleased to recommend another webinar: Analytical design space modeling in accordance with ICH Q12 and proposed Q14: Using a novel approach for in… Read More »Analytical Design Space Modeling

In the field of pharmaceutical safety, nitrosamines remain a crucial issue. In a webinar entitled “Analysis of nitrosamines in APIs by LC/MS: How to face… Read More »Challenge: Nitrosamines

Events such as the coronavirus pandemic make us aware that access to innovative, affordable and safe medicines is one of the challenges of our time… Read More »Method LifeCycle Management from Chromicent GmbH speeds up drug development considerably. Contribution of the Berlin-based company to coping with the “Corona crisis”

Dear customers and friends of Chromicent, the Chromicent, like all of us, faces great challenges. Our SOP “Pandemic Plan” was activated at the beginning of… Read More »The current situation

In accordance with Article 31 of Directive 2001/83/EC, the EMEA expects all pharmaceutical manufacturers to provide information on nitrosamines contained in medicinal drugs by the… Read More »Nitrosamine

Dear customers and friends of Chromicent, as you can see in our last year news, nitrosamines in active ingredients are still a hot topic !… Read More »Nitrosamine – SFC capacity expanded

Chromicent is pleased to present our method for the detection of pyrrolizidine alkaloids by LC-MS/MS and SFC-MS/MS developed by our project manager Maike Rehn at… Read More »Food and Environmental Forum 2020

Dear customers and friends of Chromicent, we wish you a successful new year and start with good news: At the end of 2019, the local… Read More »The Chromicent wishes you a happy new year!